Duke University Health System

Dr. Adam Perlman, Former Medical Director at Mayo Clinic, Joins Pendulum Therapeutics as Chief Medical Officer

Retrieved on: 
Tuesday, January 9, 2024

- Today, Pendulum Therapeutics , the leading microbiome biotech company pioneering the next frontier of metabolic health, announced that former Mayo Clinic Medical Director and Executive Director for Integrative Medicine at Duke University, Adam Perlman, MD, MPH, FACP, has joined the company as Chief Medical Officer.

Key Points: 
  • - Today, Pendulum Therapeutics , the leading microbiome biotech company pioneering the next frontier of metabolic health, announced that former Mayo Clinic Medical Director and Executive Director for Integrative Medicine at Duke University, Adam Perlman, MD, MPH, FACP, has joined the company as Chief Medical Officer.
  • View the full release here: https://www.businesswire.com/news/home/20240109713201/en/
    Dr. Perlman, Chief Medical Officer at Pendulum Therapeutics (Photo: Pendulum Therapeutics)
    As Chief Medical Officer at Pendulum, he will oversee the company’s clinical research portfolio, working internally and with academic collaborators to uncover new insights and inform the development of new products that will deliver strong clinical efficacy and outcomes for consumers.
  • Dr. Perlman saw first hand the efficacy of Pendulum probiotics in his practice, observing benefits in his patients with pre-diabetes and type 2 diabetes.
  • Berry joined Pendulum’s all-star lineup of investors, including Sequoia Capital, Meritech Capital, True Ventures, Khosla Ventures and the Mayo Clinic.

Prominent Anesthesiologist & Healthcare Executive Joins Surgical Directions' Strategic Advisory Board

Retrieved on: 
Tuesday, December 5, 2023

Grichnik is a highly accomplished executive with extensive experience in healthcare management and anesthesiology.

Key Points: 
  • Grichnik is a highly accomplished executive with extensive experience in healthcare management and anesthesiology.
  • As our healthcare environment continues to evolve, Surgical Directions is also rapidly growing its anesthesiology offerings for hospitals and provider groups.
  • "We are thrilled to welcome Dr. Kathy Grichnik back to Surgical Directions as a Strategic Advisory Board member," said Leslie Basham, President and CEO at Surgical Directions.
  • "She is a recognized expert in anesthesiology and healthcare leadership, and her contributions will continue to guide Surgical Directions to drive innovation, improve patient care, and navigate the complexities of the healthcare landscape.

Three North Carolina 'heavy hitters' to join State Board of Community Colleges

Retrieved on: 
Tuesday, November 28, 2023

RALEIGH, N.C., Nov. 28, 2023 /PRNewswire/ -- Three distinguished North Carolina business leaders have officially joined the State Board of Community Colleges following a swearing-in ceremony last week.

Key Points: 
  • RALEIGH, N.C., Nov. 28, 2023 /PRNewswire/ -- Three distinguished North Carolina business leaders have officially joined the State Board of Community Colleges following a swearing-in ceremony last week.
  • "The North Carolina Community College System plays a critical role in the economic development of North Carolina by providing customized workforce development training to more than 22,000 employees at over 700 existing and new companies in the state," says Christopher Chung, CEO of the Economic Development Partnership of North Carolina.
  • The State Board, which serves as the policy-making body for the North Carolina Community College System, has the responsibility of overseeing various aspects such as budgets, capital projects, and curriculum.
  • This Board is composed of 22 members, with their appointments coming from the North Carolina General Assembly and the Governor's Office.

US Radiology expands use of SCANSLATED AI-powered patient reporting to more than 110 outpatient centers nationwide; 95 percent of patients report improved understanding of imaging results

Retrieved on: 
Wednesday, October 18, 2023

The SCANSLATED platform provides patients with plain-language explanations of their complete radiology reports featuring interactive terminology definitions and diagrams throughout the report to help patients improve their understanding of medical results and enhance provider interactions.

Key Points: 
  • The SCANSLATED platform provides patients with plain-language explanations of their complete radiology reports featuring interactive terminology definitions and diagrams throughout the report to help patients improve their understanding of medical results and enhance provider interactions.
  • Patients access their easy-to-understand reports through a unique link sent via text message or email that is easily accessible from any smartphone, computer, or tablet.
  • Since implementing the technology across the majority of its outpatient imaging centers, US Radiology has received feedback from over 150,000 patients who accessed more than 4 million patient-friendly radiology definitions.
  • "SCANSLATED is a powerful example of what can happen when cutting-edge, AI-driven technology is applied to a critical clinical patient need."

Expert Panelists Advocate Use of Daxor’s Technology to Optimize Treatment at Heart Failure Society of America Annual Scientific Meeting

Retrieved on: 
Friday, October 13, 2023

Oak Ridge, TN, Oct. 13, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces that experts recommend the use of blood volume analysis (BVA) to guide optimal treatment in heart failure patient at two Scientific Sessions held during the Heart Failure Society of America Annual Scientific Meeting on October 8th & 9th, 2023, at the Huntington Convention Center in Cleveland, OH.

Key Points: 
  • The first session, titled, “Managing Congestion: Targeting Pressure vs. Volume,” was co-moderated by Dr. Arvind Bhimaraj, Houston Methodist DeBakey Heart and Vascular and Dr. Marat Fudim, Duke University Health.
  • Panel members including Dr. Wayne Miller, Mayo Clinic, Dr. Brian Howard, Wellstar, and Stephanie Barnes, CHFN, Duke University Hospital all called for the routine use of BVA to improve heart failure care.
  • Clinical use of blood volume analysis was highlighted through patient case studies presented by Dr. Howard and Stephanie Barnes.
  • Panel member Dr. Maria Rosa Constanzo, Midwest Cardiovascular Institute, stated, “assessment of congestion is complex,” and stressed the importance of monitoring congestion early before hospitalization.

Karius Test® Improves the Diagnosis and Management of Pneumonia in Patients Undergoing Treatment for Blood Cancer

Retrieved on: 
Tuesday, October 10, 2023

“Often clinicians must weigh the risks of invasive procedures in medically fragile patients with an anticipated low diagnostic yield.

Key Points: 
  • “Often clinicians must weigh the risks of invasive procedures in medically fragile patients with an anticipated low diagnostic yield.
  • Identifying the specific cause of pneumonia in patients with blood cancers who are often severely immunocompromised is difficult and critically important to successful treatment.
  • “This well-designed clinical trial conducted at leading academic centers shows that the Karius Test is highly valuable in immunocompromised patients with suspected infection,” said Dr. Ned Sharpless, former Director, National Cancer Institute, and newest Karius board member.
  • “These patients have much to gain through an improved etiologic diagnosis, and the better and more directed treatment of these infections that make this possible,” said Brad Perkins, Chief Medical Officer at Karius.

Us2.ai Partners with Leading Academic Medical Center to Collaborate on AI-Enabled Echocardiography Software

Retrieved on: 
Wednesday, September 13, 2023

In clinical practice, echocardiography is now firmly established as a central, affordable front-line tool for diagnosis and management of a range of cardiac conditions.

Key Points: 
  • In clinical practice, echocardiography is now firmly established as a central, affordable front-line tool for diagnosis and management of a range of cardiac conditions.
  • Even at the most well-resourced setting, the process of acquiring, measuring, and analyzing the images is time-consuming and labor-intensive, making the routine echocardiography application unsustainable.
  • Advances in deep learning have made automated analysis of medical images possible,” said Dr. Manesh Patel, Chief of Cardiology and Co-Director of the Heart Center at Duke University Health System.
  • This covers the vast majority of standard measurements for adult transthoracic echocardiography recommended by the American Society of Echocardiography, European Association of Cardiovascular Imaging, and British Society of Echocardiography.

IR-Med Appoints Dr. Lynn Eschenbacher to its Advisory Board as Company Advances Toward Launch of its PressureSafe Wound Care Device

Retrieved on: 
Wednesday, June 7, 2023

Dr. Eschenbacher is an innovative business development executive with extensive experience in the healthcare industry.

Key Points: 
  • Dr. Eschenbacher is an innovative business development executive with extensive experience in the healthcare industry.
  • Focused on addressing access, adherence, and affordability across the continuum of healthcare, Dr. Eschenbacher works to ensure equity .
  • She addresses impactful issues by engaging with Boards of Pharmacy, professional organizations, and the U.S. Congress.
  • Dr. Eschenbacher also held a number of positions including Medication Safety Officer at Duke University Health System.

Lifepoint Health Names Elmer Polite President of Eastern Division

Retrieved on: 
Friday, June 9, 2023

Lifepoint Health®, a diversified healthcare delivery network dedicated to making communities healthier®, has appointed Elmer Polite to the role of president, Eastern Division.

Key Points: 
  • Lifepoint Health®, a diversified healthcare delivery network dedicated to making communities healthier®, has appointed Elmer Polite to the role of president, Eastern Division.
  • Prior to his interim president role, he served as chief financial officer of the Eastern Division.
  • View the full release here: https://www.businesswire.com/news/home/20230609005271/en/
    Elmer Polite, President of Eastern Division (Photo: Business Wire)
    “Elmer is a dynamic and engaging leader who deeply understands the unique challenges and opportunities of the hospitals he oversees, and he is committed to improving their operations to ensure long-term success,” said Jason Zachariah, executive vice president and chief operating officer of Lifepoint Health.
  • “Duke has been impressed with Elmer and his leadership as interim president of the Eastern Division working with Duke LifePoint, and we are excited about his permanent appointment.

Horizon Therapeutics plc Announces Data from the TEPEZZA® (teprotumumab-trbw) Phase 4 Clinical Trial in Patients with Chronic/Low CAS Thyroid Eye Disease (TED) to be Presented at the Upcoming Endocrine Society (ENDO) Annual Meeting

Retrieved on: 
Monday, June 5, 2023

Horizon Therapeutics plc (Nasdaq: HZNP) today announced new data will be presented at the annual meeting of the Endocrine Society (ENDO 2023) in Chicago, June 15-18.

Key Points: 
  • Horizon Therapeutics plc (Nasdaq: HZNP) today announced new data will be presented at the annual meeting of the Endocrine Society (ENDO 2023) in Chicago, June 15-18.
  • TEPEZZA is the first and only medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of Thyroid Eye Disease (TED) regardless of disease activity or duration.
  • Additionally, two people living with TED will join Malini Gupta, M.D., ECNU, FACE, Director of G2Endo, for a discussion on their journey to diagnosis and experience being treated with TEPEZZA.
  • “The ENDO meeting provides an important opportunity to share results from the TEPEZZA Phase 4 clinical trial, which met its primary endpoint and demonstrated significant proptosis improvement in people who have lived with Thyroid Eye Disease for many years and have low disease activity.”